Macromolecular Nanotechnology Research Grant Needed
John Kennard
and relatively quickly became convinced that practically every aspect
of the subject(s) I examined (including the treatments of refractory
infections such as viral infections, not to mention cancer) required
for its solution the ability to develop proteins and other functional
copolymers—which I now call "biopolymers", whether natural or
artificial—for use as pharmaceuticals, including artificial hormones,
enzymes and molecular machines.
And after only about a year of pondering _that_ problem I worked out a
very crude and rudimentary technique to do just that, the theory of
which I have developed in an informal monograph through many drafts
over the last fifteen or sixteen years to one of considerable
sophistication and power, although the theory has become a dazzlingly
simple and general one at base (much more so than that of the original
technique, which has been superceded, although still mentioned late in
the book), with irrefutable experimental proof.
The technology involved obviously has applications far beyond
gerontotherapy as well; just think, for example, of being able to
easily develop any enzyme desired, as long as that enzyme is
physically possible, and the implications of that for the chemical
industry. . . .
<more:>